Middle East and Africa Diabetes Market
information, by Type (Type 1, Type 2, and Gestational diabetes), by Test
(Random blood sugar test, Fasting blood sugar test, Oral glucose tolerance
test, Initial glucose challenge test and others), by Devices (Blood glucose
monitoring devices, Diabetes management devices, and others) by Treatment
(Medications, Insulin therapy, Transplantation, Bariatric surgery and others) -
Forecast to 2023
Middle East and Africa Diabetes Market Regional
Analysis:
Considering the scenario of the Middle East and Africa
Diabetes Market, Saudi Arabia is believed to be the largest market for
diabetes. Moreover, the UAE is also growing and is the second largest market
for Middle East and Africa Diabetes. On the other hand, Egypt market is
expected to grow at significant rate in the Middle East and Africa diabetes
market during the forecasted period. Rest of Middle East and Africa is likely
to have a limited but moderate growth in the market.
Middle East and Africa Diabetes Market Players:
There are plenty of large and small market players which
operate in Middle East and Africa diabetes market are: Abbott (US), Bayer AG
(Germany), Becton Dickinson and Company (US), Johnson & Johnson Services,
Inc. (US), Merck & Co., Inc. (US), Novartis AG (Switzerland), Novo Nordisk
A/S (Denmark), Roche Diabetes Care, Inc. (US), sanofi-aventis U.S. LLC (US),
Ypsomed (Switzerland)
Request Sample Copy at: https://www.marketresearchfuture.com/sample_request/2971
Middle East and Africa Diabetes Market
Segmentation:
Middle East and Africa has led to the rapidly growing diabetes
market and expected to reach US$ 16.4 million By 2023
Middle
East and Africa Diabetes Market has been segmented on the basis
of type which comprise Type 1, Type 2, and Gestational diabetes. On the basis
of test, market is segmented into Random blood sugar test, Fasting blood sugar
test, Oral glucose tolerance test, Initial glucose challenge test and others.
On the basis of devices, it is segmented into Blood glucose monitoring devices,
Diabetes management devices, and others. On the basis of treatment market is
segmented into Medications, Insulin therapy, Transplantation, Bariatric surgery
and others.
Middle East and Africa Diabetes Market Overview
Large portion of younger population is suffering from diabetes
which is very serious problem and burden on healthcare system of Middle East
and Africa region. Type 2 diabetes is most common type of diabetes in this
region and it is observed to be most common in men than women. Increasing
number of diabetes patients is key driver for the market. Rising middle class
population, increasing per capita income results into increasing expenditure on
healthcare services is leading to the growth of the market for diabetes in this
region. Top class healthcare infrastructure and facilities, technological
advancement and availability of skilled medical professionals plays an
important role in growth of this market. Government initiatives and commitment
to improve public health are also key drivers for the market. Pharmaceutical
and device manufacturer companies are focusing on this market and spending
money in R&D to deliver innovative product for the patients which can help
them to capture maximum market share.
The Middle East and Africa Diabetes Market has been evaluated
as rapidly growing market and it is expected that the market will continue to
grow similarly in the near future. This chronic disease can lead to severe medical
conditions such as stroke, heart attack or kidney failure. From last two
decades, the prevalence of diabetes has increased rapidly in Middle East and
Africa region and about 10% of the population is suffering from diabetes. Due
to lack of body activity or exercise and eating unhealthy and junk food are
leading the growth for the market. In countries like Saudi Arabia, Kuwait,
Bahrain, Qatar and UAE, about 24%, 23%, 22%, 20% and 19% of population is
affected by this disease respectively. These countries are among the countries
with the highest prevalence of this disease. Many countries are facing the
burden of diabetes is mostly because of ageing population while in this region,
diabetes is rising in all age groups.
Middle East and Africa Diabetes Market was about USD 11.6
billion in 2016 and is expected to reach USD 16.4 billion by 2023 at a CAGR of
5.1%.
Browse Detailed TOC with COVID-19 Impact Analysis
at: https://www.marketresearchfuture.com/reports/mea-diabetes-market-2971
Browse More Research Reports at:
Leukapheresis
Products Market Research Report - Forecast to 2023 | MRFR
Facial
Injectors Market Research Report - Forecast to 2023 | MRFR
ENT
Devices Market Overview, Growth Analysis, Industry Size and Forecast to
2023
About Market Research
Future:
At Market Research Future (MRFR),
we enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw
Research Reports (3R), Continuous-Feed Research (CFR), and Market Research
& Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment